Brief: Cross Country Healthcare Q2 Adjusted EPS USD 0.1 Vs. IBES Estimate USD 0.13
31/07/2024 21:15
Jul 31 (Reuters) - Cross Country Healthcare Q2 adjusted EBITDA USD 14.178 million vs. IBES estimate USD 12.8 million. * Q2 adjusted EBITDA margin 4.2% * Q2 net income USD -16.05 million * Q2 revenue USD 339.771 million vs. IBES estimate USD 334.8 million * Q2 EPS USD -0.47 * Q2 gross margin 20.8%
Recent news on Cross Country Healthcare
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Cross Country Healthcare Q1 revenue falls 18% but beats estimates
Brief: Cross Country Healthcare Q1 Adjusted EPS USD -0.03 Vs. IBES Estimate USD -0.04
Brief: Cross Country Healthcare To Be Acquired By Knox Lane In All-Cash Transaction Valued At $437 Million